Nancy Bradish Myers, JD,
Nancy Bradish Myers, JD, President of Catalyst Healthcare Consulting, Inc., is a Washington-based attorney with deep expertise in health care law and regulation, policy development and government relations. She has been closely involved in cutting edge drug, biotechnology and medtech regulatory issues from a range of vantage points over the past two decades.
Vice President, Communications and Research
Anne McNickle, Vice President, Communications and Research at Catalyst Healthcare Consulting, Inc., specializes in regulatory strategy and communications. Ms. McNickle brings a wealth of knowledge in regulatory strategy and health policy, with over 25 years of experience.
Expert Advisor Network
Having the right experts on board impacts whether you get the best answers from regulators. At Catalyst, we pride ourselves on finding the right people with the right expertise to bring into the conversation. We build teams that FDA understands and respects.
Our Expert Advisor Network includes:
- Former FDA Division and Office heads
- Scientific experts (former FDA), including in:
- Personalized Medicine
- Neurology/diseases related to aging
- Clinical Pharmacology and Pharmacometrics
- International regulatory/harmonization experts (former FDA)
- Patient advocacy experts
- Reimbursement experts
Jill Hartzler Warner, JD,
Vice President, Regulatory Policy
Jill Hartzler Warner, Vice President, Regulatory Policy, is an expert in strategic regulatory positioning, legal analysis, policy development, and problem solving in the context of international regulatory standards. From her 30-plus-year career at FDA, she brings her depth and breadth of experience and understanding of agency approaches gleaned from her many leadership roles at the agency, including Associate Commissioner, Senior Advisor, and Associate Chief Counsel.
Ginny Hanlon, Executive Assistant
Ms. Hanlon, Executive Assistant at Catalyst Healthcare Consulting, Inc., brings an extensive background in business administration. For ten years, she worked as Senior Administrative Assistant at Eli Lilly and Company in the US Regulatory Division, and prior to that she worked for the President of NABI Biomedical Research.